🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some professionals said the demand for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

Based on the social media company, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.

Within moments of joining one community, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.